Rockefeller Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.9K	Buy	1,543 +655	+74%	+$14.6K	﹤0.01%	3450
2025 Q4	$23K	Sell	888 -983	-53%	-$23.4K	﹤0.01%	3445
2025 Q3	$48.2K	Buy	+1,871	New	+$46K	﹤0.01%	2933
2023 Q1	–	Sell	-637	Closed	-$24K	–	3333
2022 Q4	$24K	Sell	637 -278	-30%	-$13.5K	﹤0.01%	2734
2022 Q3	$48K	Sell	915 -149	-14%	-$8.29K	﹤0.01%	2371
2022 Q2	$61K	Buy	1,064 +81	+8%	+$5.31K	﹤0.01%	2197
2022 Q1	$75K	Buy	983 +7	+0.7%	+$467	﹤0.01%	2117
2021 Q4	$58K	Sell	976 -189	-16%	-$10.4K	﹤0.01%	2150
2021 Q3	$65K	Buy	1,165 +32	+3%	+$1.84K	﹤0.01%	2021
2021 Q2	$68K	Buy	1,133 +83	+8%	+$5.25K	﹤0.01%	1946
2021 Q1	$73K	Buy	1,050 +13	+1%	+$929	﹤0.01%	1746
2020 Q4	$62K	Buy	1,037 +133	+15%	+$7.79K	﹤0.01%	1610
2020 Q3	$54K	Buy	904 +603	+200%	+$35K	﹤0.01%	1486
2020 Q2	$16K	Sell	301 -62	-17%	-$2.59K	﹤0.01%	1747
2020 Q1	$12K	Buy	363 +163	+82%	+$6.77K	﹤0.01%	1691
2019 Q4	$9K	Hold	200	–	–	﹤0.01%	1641
2019 Q3	$8K	Buy	+200	New	+$7.98K	﹤0.01%	1498
2019 Q2	–	Sell	-163	Closed	-$6K	–	1891
2019 Q1	$6K	Buy	+163	New	+$6.36K	﹤0.01%	1599